14th Annual Lung Cancer Symposium

14th Annual Lung Cancer Symposium is organized by Thomas Jefferson University (TJU) Office of Continuing Professional Development (OCPD) and will be held from Mar 12 - 13, 2026 at The Warwick Hotel Rittenhouse Square Philadelphia, Philadelphia, Pennsylvania, United States of America.

Overview:
The 14th Annual Lung Cancer Symposium offers physicians, nurses, physician assistants, respiratory care specialists and public health professionals a comprehensive lung cancer update, and provide an interdisciplinary perspective of the disease, care and treatment management plans.

Objectives:
At the conclusion of this activity, healthcare team members will be able to:

1. Discuss new modalities of surgery which can lead to long-term cures and optimal results for patients with lung cancer.
2. Examine the utilization of a multidisciplinary team in the treatment of lung cancer.
3. Assess the evolving radiotherapy techniques in treatment of lung cancer.
4. Review the newest targeted molecular therapies and immunotherapies for lung cancer.
5. Explain state of the art of lung cancer prevention.
6. Evaluate the most appropriate diagnostic approach for lung nodules, lung masses, and metastatic lesions.
7. Recognize how treatment techniques vary based on lung cancer disease stage.
8. Assess the use of SBRT in early-stage lung cancer treatment.
9. Identify specific strategies to implement on lung cancer disease management as part of a continuing improvement process for clinical practices.
10. Employ lung cancer screening best practices for collaboration with multi-disciplinary teams to improve patient care.
11. Assess respiratory care treatment strategies for lung cancer patients.
12. Employ the latest community outreach strategies to reduce lung cancer disparities around the region.
13. Explain the role of sub-lobar versus lobar resection in treating lung cancer with surgical intervention.
14. Identify patients that are ideal candidates for minimally invasive, robotic surgery as a treatment for early-stage lung cancer.
15. Examine the role of education in pulmonary rehabilitation with lung cancer patients.
16. Practice multi-disciplinary collaboration with thoracic surgery, medical oncology, radiation oncology, and interventional pulmonology through a mock tumor board.
17. Apply relationship-building values and the principles of collaboration in caring for lung cancer patients.
18. Examine the role of artificial intelligence across the lung cancer care continuum.
19. Assess tobacco cessation strategies for patients across the lung cancer care continuum.
20. Compare evolving immunotherapy modalities for genetic mutations in lung cancer treatment.

Modules:
This activity offers optional pre-conference modules. The online pre-conference modules can be found on the Course Content tab. Credit count includes completion of all modules.

• Community Engaged Research to Reduce Tobacco Use Disparities/Lilianna Phan, PhD, MPH, MS
• Patient-Reported Outcomes in Lung Cancer Screening/Christopher Slatore, MD, MS
• Role of Radiation Oncology in Early Detection of Lung Cancer/Erik Blomain, MD, PhD
• Optimizing the Electronic Health Record to Improve Lung Cancer Screening Opportunities for Primary Care Populations/Bryan O’Connell, MD
• Transforming Lung Cancer Screening Through Artificial Intelligence in Thoracic Radiology/Paras Lakhani, MD
• Updates in Thoracic Surgery for Early-Stage Lung Cancer/Nathaniel R. Evans III, MD, FACS, FCCP